Nanocage-incorporated engineered destabilized 3'UTR ARE of ERBB2 inhibits tumor growth and liver and lung metastasis in EGFR T790M osimertinib- and trastuzumab-resistant and ERBB2-expressing NSCLC via the reduction of ERBB2.

Awah CU, Sun Mun J, Paragodaarachchi A, Boylu B, Nzegwu M, Matsui H, Ogunwobi O
Front Oncol. 2024 Apr 18;14:1344852. doi: 10.3389/fonc.2024.1344852. eCollection 2024. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.